Digital Health Tools for Chronic Disease: A Research Snapshot
Digital health tools for chronic disease are moving from pilot projects into daily care. Patients use apps, portals, and wearables to track symptoms, remember medications, and share readings with their care team. Clinicians want to know which tools change behavior and which ones people quietly abandon.
Three recent studies speak to that question. One surveys patients about the digital tools they already use. A second pools results from 37 trials of wearables in COPD. A third follows 60 people with lung disease through six months of home monitoring. For programs built around chronic disease management, the details behind each headline number matter as much as the numbers themselves.
What Patients Say About Digital Health Tools for Chronic Disease
Researchers at the University of Tennessee Health Science Center asked patients how they view digital health tools for chronic disease conditions such as diabetes and hypertension. The UTHSC study found that 71% of participants had already used some form of digital health technology. Their list included mobile apps, telehealth, patient portals, and remote monitoring.
Features Patients Prefer
Participants favored tools with medication reminders, diet and nutrition guidance, and access to educational resources. None of these features is complicated. Each one saves a patient a step or answers a question without a phone call.
Comfort and Acceptance
Over three-quarters of respondents felt that telemedicine and mobile health (mHealth) apps could improve chronic disease management. A similar share said they were comfortable monitoring their health data electronically and sharing it with their provider. Nearly 73% agreed that mobile apps helped them control their condition better. They pointed to the convenience of self-management and shorter waits at the clinic.
This is a survey of perceptions, not a trial of outcomes. It cannot show that apps improve blood pressure or glucose on their own. It does show that patients are open to more connected care, which is the starting point for any program that depends on daily participation.
Wearables for Chronic Disease: A Review of 37 COPD Studies
Digital health tools for chronic disease include wearables. A systematic review and meta-analysis in npj Digital Medicine, a Nature portfolio journal, looked at wearable technology in adults with chronic obstructive pulmonary disease (COPD). The authors screened more than 7,000 records and included 37 studies with 2,955 patients. Most devices were pedometers and activity trackers. Patients had a mean age of 67.
What Improved
Wearables raised the mean daily step count by about 850 steps. That gain falls inside the range researchers consider clinically meaningful for COPD, which is roughly 600 to 1,100 steps a day. Six-minute walk distance also rose, by an average of 5.81 meters. That is a real change in the data, but it sits well below the 25-meter threshold for a clinically important difference.
What Barely Moved
Scores on the COPD Assessment Test dropped by about one point. The clinically important change is two points, so quality of life shifted only slightly. Wearables did not significantly change sedentary time, time spent in moderate-to-vigorous activity, or leg strength.
Why Coaching Made the Difference
The subgroup results are the most useful part of the review. Studies that paired a wearable with health coaching or pulmonary rehabilitation did better than studies that handed patients a device alone.
- Wearable plus health coaching: about 1,000 more steps a day (998)
- Wearable alone: 243 more steps a day, not a statistically significant gain
- Wearable added to pulmonary rehabilitation: 723 more steps a day than rehabilitation alone
In other words, wearable technology worked best as one part of a care plan. A person who gets feedback, encouragement, and a goal moves more than a person who simply wears a tracker.
Limits the Authors Noted
The benefits faded in studies longer than three months. The trials varied widely in design and devices, and many had high dropout rates. The authors concluded that more work is needed on long-term effects before wearables become a routine part of COPD care.
Remote Monitoring for Respiratory Disease: A 180-Day Study
A study in JMIR Formative Research tested how well patients with lung disease stick with a home monitoring toolkit. The team enrolled 60 patients from two London hospitals. Twenty had interstitial lung disease, 20 had COPD, and 20 were recovering from COVID-19. Each person was followed for 180 days.
The toolkit combined a commercial wearable, a finger pulse oximeter, smartphone apps, and a Bluetooth home spirometer. Researchers tracked adherence, engagement, and retention across each part.
Passive Data Won on Adherence
The wearable collected data without any effort from the patient. People wore it an average of 18.66 hours a day, or 77.8% of the day. Passive monitoring showed higher adherence, engagement, and retention than every method that asked patients to do something.
Active Tasks Lost Patients Faster
Home spirometry asked the most of patients, and completion reflected it. Patients performed 4,248 of the 7,200 sessions requested, or 59%. Of those sessions, 90.3% met American Thoracic Society quality standards, so the data were usable when patients did complete them. High-burden app tasks also fell off quickly.
Retention in the COPD and interstitial lung disease groups differed significantly between patients who took scheduled protocol breaks and those who did not.
What the Authors Concluded
The authors judged remote monitoring feasible and acceptable for people with chronic respiratory disease. They pointed to low-burden, long-term passive data as especially promising. This was a small feasibility study with no control group, so it cannot show that monitoring improves outcomes. Larger studies are needed to test accuracy and clinical impact.
What These Studies Mean for Care Teams
The three studies point in the same direction. Tools that ask little of the patient hold up best.
- Lower the effort. Passive collection kept patients engaged for six months. Tasks that needed a deliberate action, like spirometry, lost people. Devices that transmit on their own protect patient adherence.
- Add a human. The COPD review found the clearest gains when a wearable came with coaching or rehabilitation. A device without follow-up produced little that could be told apart from chance.
- Plan for the first three months. Step gains were largest early and smaller later. Programs should expect a drop and plan check-ins to keep patients moving.
- Match the tool to the patient. Survey respondents favored reminders, education, and easy sharing. Those are low-effort features that fit into an ordinary day.
- Measure what matters. More steps did not translate into a clear quality-of-life gain. Track outcomes beyond activity counts.
Frequently Asked Questions
1) What are digital health tools for chronic disease?
They are apps, patient portals, telehealth platforms, wearables, and connected devices that help people track and manage a long-term condition. HHS lists remote monitoring devices, mHealth apps, and patient portals among the main technologies used for chronic disease prevention and management.
2) Do wearables help patients with COPD?
They can raise daily activity. In a review of 37 studies, wearables added about 850 steps a day on average. The effect was strongest when patients also received coaching or pulmonary rehabilitation. Wearables had little effect on quality of life.
3) Why do patients stop using home monitoring tools?
Burden is the main reason. In the 180-day respiratory study, passive wearable data had the best adherence. Home spirometry, which needs daily effort, was completed 59% of the time.
4) Do digital health tools replace clinic visits?
No. The COPD review found the best results when wearables were paired with coaching or pulmonary rehabilitation, so a clinician stays involved. Digital tools give clinicians more information between visits and give patients more insight into their own condition.
5) How long do the benefits of wearables last?
The evidence suggests the gains shrink over time. In the COPD review, step increases were smaller in studies lasting longer than three months. Longer trials are needed to know what holds up over a year or more.
6) How can care teams improve patient engagement with digital tools?
Start with tools that need little effort, such as devices that send readings automatically. Add regular contact from a clinician or coach. Offer reminders and education, which patients in the Tennessee survey said they wanted. Build in breaks and flexible support, since patients in the respiratory study who took scheduled breaks showed different retention than those who did not.
Understanding Digital Health Tools for Chronic Disease
Digital health tools for chronic disease work best when they ask little of the patient and connect to a person who responds. Patients are open to these tools, and many already use them. Wearables can raise activity in COPD, especially with coaching, but the gains fade and quality of life changes little. In respiratory monitoring, passive data kept patients engaged for six months, while high-effort tasks did not. The studies are small or short in places, so claims should stay modest. The practical lesson is clear. Choose low-burden tools, pair them with human support, and plan for engagement to dip after the first few months.
Tenovi provides cellular-connected remote patient monitoring infrastructure for RPM software companies, chronic care management companies, telehealth platforms, health systems, payers, and pharmacies. Contact us for a free demo and consultation.
